Float Short %

7.91

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

-0.19

EPS Last/This Y

0.18

EPS This/Next Y

-0.21

Price

11.35

Target Price

25.21

Analyst Recom

1.5

Performance Q

-0.79

Upside

-284.2%

Beta

0.74

Ticker: NVCR

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	NVCR	13.45	0.18	0.66	19772
2026-01-26	NVCR	13.26	0.19	8.93	20396
2026-01-27	NVCR	13.03	0.22	0.85	20935
2026-01-28	NVCR	12.57	0.23	0.30	21122
2026-01-29	NVCR	12.37	0.23	1.88	21350
2026-01-30	NVCR	12.41	0.24	0.53	21720
2026-02-02	NVCR	12.2	0.25	0.44	21875
2026-02-03	NVCR	11.85	0.25	0.26	21904
2026-02-05	NVCR	10.1	0.26	2.24	22349
2026-02-09	NVCR	10.04	0.27	2.08	22987
2026-02-10	NVCR	10.47	0.28	50.96	23248
2026-02-11	NVCR	10.51	0.36	0.40	24691
2026-02-12	NVCR	12.55	0.36	0.32	24719
2026-02-13	NVCR	10.98	0.46	1.02	33599
2026-02-17	NVCR	11.13	0.49	1.17	35119
2026-02-18	NVCR	11.39	0.50	2.75	35914
2026-02-19	NVCR	11.39	0.53	7.91	36929
2026-02-20	NVCR	11.35	0.55	1.64	37469
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	NVCR	13.45	33.5	-40.6	-1.38
2026-01-26	NVCR	13.26	33.5	-48.7	-1.38
2026-01-27	NVCR	13.03	33.5	-47.9	-1.38
2026-01-28	NVCR	12.60	33.5	-44.4	-1.38
2026-01-29	NVCR	12.37	33.5	-47.9	-1.38
2026-01-30	NVCR	12.42	33.5	-52.4	-1.38
2026-02-02	NVCR	12.19	33.5	-47.6	-1.38
2026-02-03	NVCR	11.86	33.5	-49.4	-1.38
2026-02-04	NVCR	11.57	33.5	-50.4	-1.38
2026-02-05	NVCR	10.10	33.5	-27.2	-1.38
2026-02-06	NVCR	10.14	33.5	-56.3	-1.38
2026-02-09	NVCR	10.04	32.6	-63.0	-1.38
2026-02-10	NVCR	10.48	32.6	-75.7	-1.38
2026-02-11	NVCR	10.50	32.6	-66.1	-1.38
2026-02-12	NVCR	12.55	32.6	-111.8	-1.38
2026-02-13	NVCR	10.97	32.6	-36.7	-1.38
2026-02-17	NVCR	11.12	32.6	-100.3	-1.38
2026-02-18	NVCR	11.39	32.6	-103.5	-1.38
2026-02-19	NVCR	11.39	32.6	-	-1.38
2026-02-20	NVCR	11.35	32.6	-	-1.38
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	NVCR	0.89	-5.25	8.30
2026-01-26	NVCR	0.89	-5.30	8.30
2026-01-27	NVCR	0.89	-5.30	8.30
2026-01-28	NVCR	0.89	-5.30	7.40
2026-01-29	NVCR	0.89	-5.30	7.40
2026-01-30	NVCR	0.89	-5.30	7.40
2026-02-02	NVCR	0.71	-5.14	7.37
2026-02-03	NVCR	0.73	-5.14	7.37
2026-02-04	NVCR	0.73	-5.14	7.37
2026-02-05	NVCR	0.73	-5.14	7.37
2026-02-06	NVCR	0.73	-5.14	7.37
2026-02-09	NVCR	0.73	-4.71	7.37
2026-02-10	NVCR	0.73	-4.71	7.37
2026-02-11	NVCR	0.73	-4.71	7.91
2026-02-12	NVCR	0.73	-4.71	7.91
2026-02-13	NVCR	0.73	-4.71	7.91
2026-02-17	NVCR	0.73	2.03	7.91
2026-02-18	NVCR	0.73	2.03	7.91
2026-02-19	NVCR	0.73	2.03	7.91
2026-02-20	NVCR	0.73	2.03	7.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.33

Avg. EPS Est. Current Quarter

-0.39

Avg. EPS Est. Next Quarter

-0.53

Insider Transactions

0.73

Institutional Transactions

2.03

Beta

0.74

Average Sales Estimate Current Quarter

168

Average Sales Estimate Next Quarter

150

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.1

Max Drawdown 5-Year %

-95.6

Target Price

25.21

P/E

Forward P/E

PEG

P/S

1.98

P/B

3.73

P/Free Cash Flow

EPS

-1.61

Average EPS Est. Cur. Y

-1.38

EPS Next Y. (Est.)

-1.6

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-27.66

Relative Volume

0.69

Return on Equity vs Sector %

-81.1

Return on Equity vs Industry %

-69.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1488

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y